Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1985 1
1989 1
1990 1
1991 1
1992 2
1994 1
1995 1
2006 1
2011 1
2016 1
2017 2
2019 1
2020 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
DAJIN enables multiplex genotyping to simultaneously validate intended and unintended target genome editing outcomes.
Kuno A, Ikeda Y, Ayabe S, Kato K, Sakamoto K, Suzuki SR, Morimoto K, Wakimoto A, Mikami N, Ishida M, Iki N, Hamada Y, Takemura M, Daitoku Y, Tanimoto Y, Dinh TTH, Murata K, Hamada M, Muratani M, Yoshiki A, Sugiyama F, Takahashi S, Mizuno S. Kuno A, et al. Among authors: wakimoto a. PLoS Biol. 2022 Jan 18;20(1):e3001507. doi: 10.1371/journal.pbio.3001507. eCollection 2022 Jan. PLoS Biol. 2022. PMID: 35041655 Free PMC article.
Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cells.
Kawamata T, Wakimoto A, Nishikawa T, Ikezawa M, Hamada M, Inoue Y, Kulathunga K, Salim FN, Kanai M, Nishino T, Gentleman K, Liu C, Mathis BJ, Obana N, Fukuda S, Takahashi S, Taya Y, Sakai S, Hiramatsu Y. Kawamata T, et al. Among authors: wakimoto a. Sci Rep. 2023 Dec 18;13(1):22469. doi: 10.1038/s41598-023-48562-y. Sci Rep. 2023. PMID: 38110459 Free PMC article.
Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
Yoshino K, Kamiura S, Yokoi T, Nakae R, Fujita M, Takemura M, Adachi K, Wakimoto A, Nishizaki T, Shiki Y, Tsutsui T, Kanda Y, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Sawada K, Tomimatsu T, Kimura T. Yoshino K, et al. Among authors: wakimoto a. Cancer Chemother Pharmacol. 2017 Dec;80(6):1239-1247. doi: 10.1007/s00280-017-3468-5. Epub 2017 Oct 28. Cancer Chemother Pharmacol. 2017. PMID: 29080971 Clinical Trial.
Lymphangioleiomyoma of the Uterus and Pelvic Lymph Nodes: A Report of 3 Cases, Including the Potentially Earliest Manifestation of Extrapulmonary Lymphangioleiomyomatosis.
Ando H, Ogawa M, Watanabe Y, Tsurunaga K, Nakamura C, Tamura H, Ikeda K, Takahashi R, Nakajima R, Yoshida S, Tsujie T, Doi R, Wakimoto A, Adachi S. Ando H, et al. Among authors: wakimoto a. Int J Gynecol Pathol. 2020 May;39(3):227-232. doi: 10.1097/PGP.0000000000000589. Int J Gynecol Pathol. 2020. PMID: 30789500
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.
Egawa-Takata T, Ueda Y, Kuragaki C, Miyake T, Miyatake T, Fujita M, Yoshino K, Nakashima R, Okazawa M, Tsutsui T, Morishige K, Kimura T, Yamasaki M, Nishizaki T, Nagamatsu M, Ito K, Asada M, Ogita K, Wakimoto A, Yamamoto T, Nishio Y, Enomoto T. Egawa-Takata T, et al. Among authors: wakimoto a. Cancer Chemother Pharmacol. 2011 Dec;68(6):1603-10. doi: 10.1007/s00280-011-1638-4. Epub 2011 May 17. Cancer Chemother Pharmacol. 2011. PMID: 21584840 Clinical Trial.
23 results